Lanthanum carbonate decreases PTH gene expression with no hepatotoxicity in uraemic rats | Zendy

Iddo Z. BenDov | Zendy; Orit Pappo | Zendy; M. Sklair-Levy | Zendy; Hillel Galitzer | Zendy; Yaron Ilan | Zendy; Tally NavehMany | Zendy; J. Silver | Zendy

AI Assistant Blog Pricing

Home ZAIA Blog

Open Access

Lanthanum carbonate decreases PTH gene expression with no hepatotoxicity in uraemic rats

Author(s) -

Iddo Z. BenDov,

Orit Pappo,

M. Sklair-Levy,

Hillel Galitzer,

Yaron Ilan,

Tally NavehMany,

J. Silver

Publication year - 2006

Publication title -

nephrology dialysis transplantation

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 1.654

H-Index - 168

eISSN - 1460-2385

pISSN - 0931-0509

DOI - 10.1093/ndt/gfl623

Subject(s) - lanthanum carbonate , medicine , gene expression , endocrinology , gene , pharmacology , biochemistry , kidney disease , hyperphosphatemia , chemistry

Lanthanum (La) carbonate is an effective phosphate-binder, used to reverse hyperphosphataemia due to chronic kidney disease. Some recent studies in rodents have cast safety uncertainties. The aims of this study were to examine the effects of La on parathyroid hormone (PTH) gene expression and hepatic toxicity.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research